Clinical trial Recruiting at 18 sites Phase 3 Interventional Ages 23 Weeks to 29 Weeks

Doxapram treatment for preterm infants with breathing issues

Official title: Doxapram Versus Placebo in Preterm Newborns: An International Double Blinded Multicenter Randomized Controlled Trial

Run by Erasmus Medical Center · NCT04430790 · Data updated 2026-11-12

This study is testing if doxapram can help preterm infants with breathing problems avoid serious complications and reduce the need for breathing machines.

Quick facts

PhasePhase 3
Study typeInterventional
Ages23 Weeks to 29 Weeks
SexAll
Enrollment396 (estimated)
SponsorErasmus Medical Center
Academic / other
Locations24 sites (Brussels, Avenaue Hippocrate 10 and 23 other locations)
StatusRecruiting
StartedJune 15, 2020
Main results expectedMay 1, 2026
Study endsMay 1, 2034
Registry record updatedApril 4, 2024
Trial IDNCT04430790 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are preterm infants born at less than 29 weeks gestational age who are admitted to a neonatal intensive care unit and require medical intervention for apnea.

Probably not a fit

Patients with major congenital malformations or chromosomal defects that compromise lung function or increase the risk of adverse outcomes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the safety and effectiveness of doxapram, a respiratory stimulant, in reducing the risk of death and neurodevelopmental impairment in preterm infants suffering from apnea of prematurity. Conducted in multiple neonatal intensive care units across the Netherlands and Belgium, the study involves a multicenter, double-blinded, randomized, placebo-controlled design. Infants will be randomly assigned to receive either doxapram or a placebo, with treatment administered continuously until the patient's condition allows for discontinuation. The trial aims to provide insights into whether doxapram can prevent the need for invasive mechanical ventilation in these vulnerable patients.

Why it matters

Potential benefit: If successful, this treatment could significantly reduce the incidence of severe disability and improve survival rates in preterm infants with apnea of prematurity.

How similar studies have gone: Previous studies have shown promise in using respiratory stimulants like doxapram for treating apnea of prematurity, but this specific trial aims to provide more definitive evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Admitted to the neonatal intensvie care unit (NICU) of one of the participating centres
* Written informed consent of both parents or legal representatives
* Gestational age at birth \< 29 weeks
* Caffeine therapy, adequately dosed (see also under co-medication)
* Optimal Non-invasively supported with nasal Continuous Positive Airway Pressure (CPAP) or ventilation ((S)NIPPV, NIV-NAVA, BIPAP/Duopap, SIPAP)
* Apnea that require a medical intervention as judged by the attending physician

Exclusion Criteria:

* Previous use of open label doxapram
* Use of theophylline (to replace doxapram)
* Chromosomal defects (e.g. trisomy 13, 18, or 21)
* Major congenital malformations that: compromise lung function (e.g. surfactant protein deficiencies, congenital diaphragmatic hernia); result in chronic ventilation (e.g. Pierre Robin sequence); increase the risk of death or adverse neurodevelopmental outcome (congenital cerebral malformations, chromosomal abnormalities);
* Palliative care or treatment limitations because of high risk of impaired outcome.

Where it's running

  • St Luc Louvain
    Brussels, Avenaue Hippocrate 10, Belgium
    Recruiting
  • Delta Hospital Brussels
    Brussels, Brussels Capital, Belgium
    Recruiting
  • University Hospital Brussels
    Jette, Brussels Capital, Belgium
    Recruiting
  • Grand Hospital de Charleroi
    Charleroi, Henegouwen, Belgium
    Recruiting
  • Academisch Ziekenhuis Sint-Jan
    Bruges, West-Vlaanderen, Belgium
    Recruiting
  • Sint Augustinus Hospital Antwerp
    Antwerp, Belgium
    Recruiting
Show 18 more locations
  • University Hospital Antwerp
    Antwerp, Belgium
    Recruiting
  • Chirec-Delta Hospital
    Brussels, Belgium
    Recruiting
  • University Hospitals Leuven
    Leuven, Belgium
    Recruiting
  • Radboudumc Amalia Children's Hospital Nijmegen
    Nijmegen, Gelderland, Netherlands
    Recruiting
  • Maastricht University Medical Center
    Maastricht, Limburg, Netherlands
    Recruiting
  • Maxima Medical Center Veldhoven
    Veldhoven, North Brabant, Netherlands
    Recruiting
  • Amsterdam University Medical Center
    Amsterdam, North Holland, Netherlands
    Recruiting
  • Isala Clinics Zwolle
    Zwolle, Overijssel, Netherlands
    Recruiting
  • Leiden University Medical Center
    Leiden, South Holland, Netherlands
    Recruiting
  • Erasmus Medical Center - Sophia Children's Hospital
    Rotterdam, South Holland, Netherlands
    Recruiting
  • University Medical Center Groningen
    Groningen, Netherlands
    Recruiting
  • UMC Utrecht - Wilhelmina Kinderziekenhuis
    Utrecht, Netherlands
    Recruiting
  • Clinique Saint-Vincent Liege
    Liège, Liege, Belgium
    Suspended
  • Foothills Medical Centre
    Calgary, Alberta, Canada
    Not yet recruiting
  • Royal Alexandra Hospital
    Edmonton, Alberta, Canada
    Not yet recruiting
  • McMaster Children's Hospital
    Hamilton, Ontario, Canada
    Not yet recruiting
  • Montreal Children's Hospital
    Montreal, Quebec, Canada
    Not yet recruiting
  • Centre Mère-Enfent Soleil
    Québec, Quebec, Canada
    Not yet recruiting

Study contacts

  • Principal investigator: Anne Smits, MD, PhD — Universitair Ziekenhuis Leuven
  • Study coordinator: Sinno HP Simons, MD, PhD
  • Email: s.simons@erasmusmc.nl
  • Phone: +31641376695

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.